Financings In Brief
This article was originally published in The Gray Sheet
Executive SummarySpine Wave raises $45 million: Spinal implant developer Spine Wave raises $45 million in a private placement to support expansion of its U.S. sales force and global distribution network, as well as R&D efforts and clinical trials, the firm says. Shelton, Conn.-based Spine Wave's U.S. offerings include the StaXx XD expandable polyetheretherketone (PEEK) spacer for vertebral body replacement and the CapSure PS top loading pedicle screw system for treating degeneration, tumor, or trauma of the thoracolumbar spine. Outside the United States the firm also offers the StaXx FX minimally invasive system for repairing vertebral compression fractures, and the NuCore injectable nucleus for early-stage degenerative disc disease. Founded in 2001 by former execs of spinal device powerhouse Sofamor Danek, privately held Spine Wave's latest financing round was led by Compass Global Fund...
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.